Switch theme
Sign up to access all valuation multiples
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC related work, PMS facility contract support related work, clinical research support / monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments such as monitoring, safety information, data management and statistical analysis. It provides support for the development of generic drugs such as bioequivalence studies and biosimilars, clinical research and physician-led clinical trials.
1984
n/a
LTM Revenue $36.6M
Last FY EBITDA $9.0M
$30.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
WDB coco has a last 12-month revenue (LTM) of $36.6M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, WDB coco achieved revenue of $31.5M and an EBITDA of $9.0M.
WDB coco expects next 12-month revenue of XXX and NTM EBITDA of XXX
See WDB coco valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $36.6M | XXX | $31.5M | XXX | XXX | XXX |
| Gross Profit | $36.6M | XXX | $13.3M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 42% | XXX | XXX | XXX |
| EBITDA | n/a | XXX | $9.0M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 28% | XXX | XXX | XXX |
| EBIT | $9.0M | XXX | $8.7M | XXX | XXX | XXX |
| EBIT Margin | 25% | XXX | 28% | XXX | XXX | XXX |
| Net Profit | $6.3M | XXX | $5.9M | XXX | XXX | XXX |
| Net Margin | 17% | XXX | 19% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, WDB coco's stock price is JPY 2915 (or $20).
WDB coco has current market cap of JPY 7.0B (or $48.1M), and EV of JPY 4.4B (or $30.0M).
See WDB coco trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $30.0M | $48.1M | XXX | XXX | XXX | XXX | $2.61 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, WDB coco has market cap of $48.1M and EV of $30.0M.
WDB coco's trades at 1.0x EV/Revenue multiple, and 3.5x EV/EBITDA.
Equity research analysts estimate WDB coco's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
WDB coco has a P/E ratio of 7.7x.
See valuation multiples for WDB coco and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $48.1M | XXX | $48.1M | XXX | XXX | XXX |
| EV (current) | $30.0M | XXX | $30.0M | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 3.5x | XXX | XXX | XXX |
| EV/EBIT | 3.4x | XXX | 3.6x | XXX | XXX | XXX |
| EV/Gross Profit | 0.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 7.7x | XXX | 8.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 7.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialWDB coco's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
WDB coco's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
WDB coco's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for WDB coco and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 28% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 15% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Jubilant Pharmova | XXX | XXX | XXX | XXX | XXX | XXX |
| Biocon | XXX | XXX | XXX | XXX | XXX | XXX |
| Syngene International | XXX | XXX | XXX | XXX | XXX | XXX |
| Dishman Carbogen Amics | XXX | XXX | XXX | XXX | XXX | XXX |
| Cohance Lifesciences | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
WDB coco acquired XXX companies to date.
Last acquisition by WDB coco was XXXXXXXX, XXXXX XXXXX XXXXXX . WDB coco acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was WDB coco founded? | WDB coco was founded in 1984. |
| Where is WDB coco headquartered? | WDB coco is headquartered in Japan. |
| Is WDB coco publicy listed? | Yes, WDB coco is a public company listed on TKS. |
| What is the stock symbol of WDB coco? | WDB coco trades under 7079 ticker. |
| When did WDB coco go public? | WDB coco went public in 2019. |
| Who are competitors of WDB coco? | Similar companies to WDB coco include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics. |
| What is the current market cap of WDB coco? | WDB coco's current market cap is $48.1M |
| What is the current revenue of WDB coco? | WDB coco's last 12 months revenue is $36.6M. |
| What is the current EV/Revenue multiple of WDB coco? | Current revenue multiple of WDB coco is 0.8x. |
| Is WDB coco profitable? | Yes, WDB coco is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
